You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CRYSTODIGIN Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

When do Crystodigin patents expire, and when can generic versions of Crystodigin launch?

Crystodigin is a drug marketed by Lilly and is included in one NDA.

The generic ingredient in CRYSTODIGIN is digitoxin. Additional details are available on the digitoxin profile page.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for CRYSTODIGIN?
What are the global sales for CRYSTODIGIN?
What is Average Wholesale Price for CRYSTODIGIN?

Summary for CRYSTODIGIN

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	62
Patent Applications:	5,963
DailyMed Link:	CRYSTODIGIN at DailyMed

Drug patent expirations by year for CRYSTODIGIN

US Patents and Regulatory Information for CRYSTODIGIN

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Lilly	CRYSTODIGIN	digitoxin	INJECTABLE;INJECTION	084100-005	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.